Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7473442rdf:typepubmed:Citationlld:pubmed
pubmed-article:7473442lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7473442lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:7473442lifeskim:mentionsumls-concept:C0024153lld:lifeskim
pubmed-article:7473442lifeskim:mentionsumls-concept:C0243067lld:lifeskim
pubmed-article:7473442lifeskim:mentionsumls-concept:C0873071lld:lifeskim
pubmed-article:7473442pubmed:issue7lld:pubmed
pubmed-article:7473442pubmed:dateCreated1995-12-4lld:pubmed
pubmed-article:7473442pubmed:abstractTextVaginal progesterone suppositories are an accepted treatment for infertility attributed to luteal phase defects. Although oral micronized progesterone may be preferable to suppositories for many patients, there are no studies on its use for patients with luteal phase defects. This study evaluated the efficacy of oral micronized progesterone for the treatment of luteal phase defects.lld:pubmed
pubmed-article:7473442pubmed:languageenglld:pubmed
pubmed-article:7473442pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7473442pubmed:citationSubsetIMlld:pubmed
pubmed-article:7473442pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7473442pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7473442pubmed:statusMEDLINElld:pubmed
pubmed-article:7473442pubmed:monthJullld:pubmed
pubmed-article:7473442pubmed:issn0024-7758lld:pubmed
pubmed-article:7473442pubmed:authorpubmed-author:LucianoA AAAlld:pubmed
pubmed-article:7473442pubmed:authorpubmed-author:NulsenJ CJClld:pubmed
pubmed-article:7473442pubmed:authorpubmed-author:FrishmanG NGNlld:pubmed
pubmed-article:7473442pubmed:authorpubmed-author:KlockS CSClld:pubmed
pubmed-article:7473442pubmed:issnTypePrintlld:pubmed
pubmed-article:7473442pubmed:volume40lld:pubmed
pubmed-article:7473442pubmed:ownerNLMlld:pubmed
pubmed-article:7473442pubmed:authorsCompleteYlld:pubmed
pubmed-article:7473442pubmed:pagination521-4lld:pubmed
pubmed-article:7473442pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:meshHeadingpubmed-meshheading:7473442-...lld:pubmed
pubmed-article:7473442pubmed:year1995lld:pubmed
pubmed-article:7473442pubmed:articleTitleEfficacy of oral micronized progesterone in the treatment of luteal phase defects.lld:pubmed
pubmed-article:7473442pubmed:affiliationDepartment of Obstetrics and Gynecology, University of Connecticut, Farmington, USA.lld:pubmed
pubmed-article:7473442pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7473442pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7473442lld:pubmed